Abstract
Introduction
Patient-initiated second opinions have become increasingly common in recent years. However, the frequency, motivations and advantages/disadvantages of this approach remain unclear. This study assessed the incidence and impact of patient-initiated second opinions in oncology patients.
Methods
Literature searches of PubMed and Google Scholar were performed to identify peer-reviewed publications on patient-initiated second opinions in oncology patients published between 06/01/2004 and 06/01/2024. Selected publications evaluated the frequency, patient characteristics and motivating factors of patient-initiated second opinions and their impact on diagnoses, treatment, prognoses and patient satisfaction.
Results
Sixty peer-reviewed publications were included in the analysis. Data showed highly variable rates of second-opinion seeking. Younger age, female gender, higher educational level, advanced disease, socioeconomic status and having health insurance were associated with an increased likelihood of this approach. The most common patient-reported reasons for seeking a second opinion were to gain more information, seek reassurance, access expert guidance, and check the accuracy of proposed treatments. Patient-initiated second opinions led to changes in diagnosis, treatment, or prognosis in up to 69% of cases and a greater likelihood of guideline-compliant recommendations; however, wide variability in reported rates precludes drawing firm conclusions. Patient satisfaction with second-opinion consultations was high and these were deemed helpful and reassuring in most cases.
Conclusion
Increasing numbers of cancer patients are seeking second opinions, and these may have a considerable impact on diagnoses, outcomes and patient satisfaction. Improved patient education and further research regarding the impact of patient-initiated second opinions and barriers to access would be beneficial.
Keywords: patient-initiated, second opinion, clinical oncology, patients
Implications for Practice.
As more patients seek second opinions, oncology teams should ensure that access pathways are clear, equitable and easy to navigate. Improved communication during initial consultations may reduce unnecessary requests while supporting informed decision-making. Given that second opinions can reveal guideline deviations and lead to clinically meaningful changes in management, incorporating structured opportunities for secondary review may enhance care quality, especially for complex cases and patients with advanced cancers. Efforts to improve patient education and address demographic and geographic barriers will be essential to ensuring that all patients can benefit from this important component of cancer care.
Introduction
Patients now have unprecedented access to medical information, enabling them to evaluate recommendations, seek alternative counsel, and pursue second opinions.1–5 In oncology, where diagnostics and therapies are complex and outcomes critical, patient-initiated second opinions are increasingly common,6–10 with most oncologists providing several consultations per month.1,5,6,11–13
A patient-driven second opinion can be defined as a patient soliciting independent guidance on diagnosis, prognosis or treatment options from another physician within the same specialty, often with the intention of returning to the original provider.1,2,6
Reported benefits of second opinions include improved diagnostic accuracy,6,14,15 greater adherence to guidelines,14 more individualized6,16 or de-escalated treatment,17 and access to novel diagnostics, technologies and clinical trials,11,18 which is particularly relevant in rare malignancies.7 Second opinions may also reduce over- and under-treatment and medical errors.8,16,19,20
However, second opinions are not without their challenges, including the potential for diagnostic discrepancies,8,9,20,21 treatment delays,4,6,8,22 dissatisfaction with the primary clinician,23 patient confusion,6 and increased clinician workloads.6,8,24 While second opinions are often sought for reassurance,6 up to two-thirds result in changes in diagnosis or treatment.6,8,9
Despite growing interest in patient-centered care, the evidence base for patient-initiated second opinions remains limited.1,9,16 Only 5 systematic reviews on this topic were published between 2004 and 2024,6–10 of which 3 focused on oncology (Table S1).6,7,10 Most studies are in breast cancer,25 with substantially fewer in other tumor types, particularly rare cancers.26 The literature remains fragmented, with inconsistent prevalence estimates, limited reporting of equity factors (eg, socioeconomic status, insurance, ethnicity), and little exploration of long-term outcomes.6,8,9,27–29
This review focuses on patient-initiated second opinions in oncology, examining which patients seek them, their motivations, and the resulting clinical impact.
Materials and methods
Structured searches of PubMed and Google Scholar were conducted to identify peer-reviewed manuscripts, posters, and congress abstracts published between June 1, 2004 and June 1, 2024 that examined patient-initiated second opinions in oncology. Searches combined patient-referral terms (eg, second opinion/second medical opinion, patient request, self-initiated), tumor-related terms (cancer, oncology, tumor, neoplasm, sarcoma, hematology), and publication-type descriptors (meta-analysis, systematic review, review, observational or clinical study, interview, survey, retrospective review). Exclusion criteria comprised non-patient-initiated consultations; non-English or non-peer-reviewed publications; case reports or case series; studies focusing on non-oncology or palliative-care populations; and ethics consultations, guidelines, editorials, commentaries, or unpublished material. Studies from other medical specialties were included only if oncology-specific outcomes were reported separately. Only papers explicitly addressing second opinions were included; citations without such content and pathology studies describing physician-initiated reviews were excluded. Forward and backward citation searches of eligible papers were performed to ensure completeness.
The review was guided by predefined questions examining: the proportion of patients who request a second opinion; the clinical and demographic characteristics of those who do so; their motivations; the independence, guideline concordance, and alignment of second-opinion recommendations with initial recommendations; patient satisfaction with second-opinion consultations; and potential inequities in access to or outcomes from second opinions based on patient-related factors.
Results
A total of 127 publications were identified through database and citation searches. Sixty-seven publications were excluded: second opinions were not patient-initiated (n = 27); non-oncology focus (n = 15); out of scope (n = 10); editorials/commentaries/magazine articles (n = 9); non-English (n = 3); or published before 2004 (n = 3). Sixty publications met the inclusion criteria and were utilized in the analysis.
Most included studies were quantitative cohort/cross-sectional surveys (n = 22), retrospective chart/imaging reviews (n = 16), or qualitative interviews/focus groups (n = 8). Additional designs included policy/health service evaluations (n = 6), systematic reviews/meta-analyses (n = 5), longitudinal mixed-methods studies (n = 2), and 1 conceptual paper (Table S1). Patient selection procedures varied by study methodology.
Proportion of patients requesting a second opinion
Reported rates of second-opinion seeking among patients with cancer varied widely, ranging from 6.5% to 42% across studies.1,4,10,13,25–33 Questionnaire-based surveys conducted in Australia, Germany, Hong Kong, the Netherlands and the US illustrate this variation, with rates of 6.5% (123/1892),1 16.1% (57/355),31 23% (427/1856),26 33% (17/52),13 34% (36/106),30 40% (950/2365),32 and 42% (80/191)33 (Table 1).
Table 1.
Variables associated with second-opinion seeking in oncology patients (presented alphabetically by variable).
| Variable | Cancer type | Country | Summary of evidence |
|---|---|---|---|
| Age | Breast,12,36 colorectal,34,36 prostate,32,36 mixed1,35 | Australia,12 Germany,1 India,35 ,12 United States32,34,36 | |
| Cancer type | Breast,4 gynecologic,33 prostate,32 rare,26 mixed1,13,30 | Australia,1,13 Germany,30Hong Kong,33 the Netherlands,26 United States4,32 | |
| Disease stage | Breast,4,43 bladder,44 colorectal,34 gynecologic,33 prostate,44 mixed31,35,44 | Australia,31 France,44 Hong Kong,33 India,35 United States4,34,43 |
|
| Educational attainment | Breast,36,38 colorectal,36,38 gynecologic,33 lung,38 prostate,32,36 mixed1,6,8,31 | Australia,1,31 Hong Kong,33 8 international6,8 United States32,36–38 | |
| Gender | Mixed1,6,8,9,30 | Australia,1 Germany,30International, 6,8,9 | |
| Geographic factors | Breast,37 mixed35 | India,35 United States37 | |
| Health insurance | Lung/colorectal,38 prostate,32 mixed31 | Australia,31 United States32,38 | |
| Healthcare system factors | Breast37 | United States37 |
|
| Race/ethnicity | Breast,4,42 lung/colorectal,34,38 prostate41 | United States4,34,38,41,42 |
|
| Socioeconomic status | Breast,22,37,38 lung/colorectal,38 mixed8,40 | Israel,8,40 , United States22,37,38 | |
| Treatment modality | Gynecologic,33 mixed39 | Hong Kong,33 Japan39 |
Abbreviations: SES, socioeconomic status; SO, second opinion.
Characteristics of patients requesting a second opinion
Across studies, second-opinion seeking was typically more common among younger, female patients,1,6,8,9,12,32,34–36 individuals with higher educational attainment1,6,8,32,33,36–39 or socioeconomic status,8,22,37,38,40 and those with health insurance.31,32,38 However, these associations were not consistent, with several studies reporting contradictory findings.4,6,30,31 A number of publications reported racial and linguistic disparities, although findings were not uniform.4,34,38,41,42 Disease stage,4,31,33–35,43,44 tumor type,1,3,4,26,30,33 and treatment modality33,39 also influenced second-opinion requests, with higher rates observed in some advanced/recurrent9,33–35 and complex cases,44 and among patients receiving radiotherapy.33,39 Geographic and healthcare-system factors, including urban versus non-urban residence, referral pathways, and access to specialist centers, further shaped patterns of second-opinion seeking.35,37 These variables and the supporting evidence are summarized in Table 1.
Patient-reported reasons for requesting a second opinion
Patients most commonly sought a second opinion to seek reassurance about or confirm the correctness of the diagnosis and proposed treatment plan1,13,27,30–32,40,45–50; to access expert guidance27,30,32,45,46,51; or to obtain additional information.1,27,30,32,46,49,51 Dissatisfaction with or poor understanding of the initial information provided1,12,30,51; uncertainty about their situation27,30,31,47,51; and dissatisfaction with or lack of trust in the first clinician12,29,31,46,51 also contributed. Clinical trial opportunities were reported less frequently as reasons for seeking a second opinion.31,45,49,51 These motivations are summarized in Table 2.
Table 2.
Motivations most commonly reported by oncology patients for seeking a second opinion (ranked from highest to lowest frequency).
| Patient-reported motivations | Frequency (% of surveyed patients) |
|---|---|
| Seeking confirmation or reassurance about the proposed diagnosis or treatment plan1,13,27,30–32,40,45–50 | 49-811,30,31,46 |
| Desire to consult the “best doctor,” access expert guidance, or understand what other specialists would advise27,30,32,45,46,51 | 46-7030,32,45,46,51 |
| Seeking additional information about the diagnosis, prognosis or available treatment options1,27,30,32,46,49,51 | 24-751,30,32,46,49,51 |
| Dissatisfaction with or poor understanding of the information provided initially1,12,30,51 | >15-311,30,51 |
| Dissatisfaction with, poor relationship with, or lack of trust in the initial treating clinician12,29,31,46,51 | 10-2429,31,46,51 |
| Uncertainty or confusion regarding their clinical situation and the information received27,30,31,47,51 | 7-1631,51 |
| Clinical trial opportunities31,45,49,51 | 3-1031,45,49,51 |
Are second-opinion recommendations independent, guideline-compliant and do they align with first-opinion recommendations?
Independence and concordance between first- and second-opinion recommendations displayed considerable variation across studies (Table 3).10,17,25,29,44,50,52–57 First-opinion recommendations, inter-physician dynamics, and the public nature of second opinions were all reported to influence outcomes.50,52
Table 3.
Independence, guideline compliance, and concordance between first and second opinions in self-referred oncology patients.
| Country | Study type | Population, N | Key findings |
|---|---|---|---|
| Independence of second-opinion recommendations | |||
| The Netherlands52 | Qualitative interview | Oncologists/hematologists (N = 26) |
|
| Guideline compliance and quality of first- and second-opinion recommendations | |||
| Germany14 | Oncology patients, mixed (N = 584) |
|
|
| Germany58 | Retrospective, observational | Patients with breast/gynecologic cancers (N = 164) |
|
| Levels of concordance between first and second opinions | |||
| 10 | Systematic review | Oncology patients, mixed |
|
| The Netherlands29 | Longitudinal mixed-methods | Oncology/hematology specialists (N = 24) |
|
| United States17 | Retrospective chart/imaging review | Oncology patients, mixed (N = 120) |
|
| United States55 | Policy/health services/economic evaluation | Patients across medical specialties seeking SOs (N = 6791); medical oncology/hematology (n = 588) |
|
| Discrepancies between first and second opinions by cancer type: breast cancer | |||
| The Netherlands25 | Retrospective chart/imaging review | N = 591 |
|
| United States56 | Retrospective chart/imaging review | N = 1970 |
|
| United States53 | Retrospective chart/imaging review | N = 147 (176 lesions) |
|
| Discrepancies between first and second opinions by cancer type: urologic cancers | |||
| France44 | Patients across medical specialties (N = 1552), including bladder (n = 12) and prostate (n = 46) cancers |
|
|
| United States54 | Cohort/cross-sectional survey (quantitative) | Survey of patients with prostate cancer (N = 238) and their urologists |
|
| Discrepancies between first and second opinions by cancer type: lung cancer | |||
| The Netherlands57 | Retrospective chart/imaging review | Patients with lung cancer (N = 188) |
|
| Impact of who initiates the second opinion | |||
| United States69 | Retrospective chart/imaging review | Patients with prostate cancer (N = 684) |
|
Abbreviations: IBR, immediate breast reconstruction; OR, odds ratio; SO, second opinion.
Guideline compliance was inconsistent. In breast and gynecologic cancers, 35% of primary consultations were non-compliant, while second opinions optimized care in 57%.58 In a mixed oncology cohort, at least 20% of patients would not have received fully guideline-based recommendations without a second opinion.14
Reported rates of discrepancies between first- and second-opinion consultations varied widely between analyses (5%-69%).10,17,25,29,44,53–57 Second opinions resulted in clinically meaningful changes in diagnosis, staging and, particularly, treatment recommendations across multiple tumor types (breast,25,53,56 lung,57 and prostate/bladder44,54 cancers). Alterations in patient management resulting from second opinion consultations were shown to affect outcomes, particularly in patients with advanced disease.17,57 Impacts varied by tumor type, resulting in shifts toward surgical management in urologic cancers,54 and changes in treatment sequencing in breast cancer.25
Patient satisfaction with second-opinion consultations
Across multiple settings, patient satisfaction with second-opinion consultations was consistently high.10,13,30,46 In Australia (N = 52)13 and Germany (N = 10630 and N = 16446) between 79% and 94% of patients described second opinions as helpful and reassuring, and 90% of patients in one study reported feeling better informed than after their initial consultation (P < .0001).46 These gains were linked to increased reassurance and improved communication.13,46 Findings from the Netherlands (N = 70)51 showed a more nuanced pattern; although 66% of patients with advanced disease expected different outcomes, most ultimately found the second opinion to be either “largely” (56%) or “completely” (33%) consistent with the first. This alignment reduced uncertainty but did not lessen anxiety.51
Patient satisfaction with second opinions also varied depending on subsequent care pathways. In a prospective study of 69 patients and 24 oncologists,23 those referred back to their original institution after receiving a second opinion were significantly less satisfied than those who were transferred to the second-opinion center (P = .028). Educational background also appeared to influence confidence; at an Australian cancer center (N = 77),1 67% of patients with secondary education felt confident following a second opinion, compared with 36% of those with tertiary education (P = .046).
Are there inequities in access to or outcomes from a second opinion based on patient-related factors?
Evidence across multiple settings indicated potential inequities in access to second opinions relating to insurance status/income, ethnicity, education/health literacy, and geography (Table 1).1,4,12,26,31–34,37,38,41–43
Uninsured oncology patients were substantially less likely than insured patients to obtain a second opinion in both Australian (N = 355)31 and US (N = 2365)32 cohorts. Further inequities were observed among women with ductal carcinoma in situ (N = 710), where Spanish-speaking Latinas accessed second opinions less often than White or English-speaking Latina women.42 Several studies also reported lower rates of second-opinion seeking among individuals with lower versus higher educational attainment,1,32,33,36–38 and among Black compared with White patients,38,41 alongside greater mistrust of clinicians among Black patients.41 Geographic variation contributed as well; Dutch patients with rare cancers (n = 1856) were significantly more willing than those with common cancers (n = 5487) to travel further for specialist input (55% vs. 47%, P < .001), highlighting uneven access to specialist services.26
Summary
In this analysis, multiple studies showed that second opinions can meaningfully alter diagnoses, treatment recommendations, or prognoses, with reported changes in up to 69% of cases.10,17,20,25,44,56,57 Despite this potential impact, published rates of second-opinion seeking varied widely.1,4,9,24–33 This reflects heterogeneity in tumor type,1,3,4,26,30,32,33 disease stage,4,31,33–35,43,44 patient characteristics,1,6,8,9,12,18,22,31–40 treatment modality,33,39 and geographic setting.35,37
Patterns of second-opinion use differed markedly across healthcare systems.6,10,24 In the US17,32,34,38,43,48 and Australia,1,13,50 second opinions were often associated with changes in treatment plans or improvements in guideline adherence, whereas in continental Europe they were more commonly embedded in structured cancer-center programs focused on quality assurance.6,7,12,14,23,46,58–61 In Israel, second opinions were highly utilized and examined through a health-policy lens,8,16,19,24 while in the Asia-Pacific region they were more strongly shaped by cultural norms, with less emphasis on clinical discordance.33,39,62
Data showed racial and socioeconomic inequities in access to and outcomes from second opinions.6,8,22,31,32,37,38,40 Patients with rare cancers appeared more willing to travel further for specialist care than those with common cancers,26 while low income and African American or Latin American ethnicities were associated with greater treatment delays following second opinions in breast cancer.22 UK data suggest that Caribbean, African and Asian women with breast or ovarian cancer face higher odds of late-stage diagnosis than White women,63 which may deter second-opinion seeking. Low socioeconomic status and lack of health insurance also restrict access, disproportionately affecting minority groups.64 Across studies, higher socioeconomic status,6,8,22,37,38,40 and insurance coverage31,32,38 consistently predicted second-opinion seeking. However, most of the studies in this analysis derived from the US, limiting generalizability to universal healthcare systems.
Reported incidences of second-opinion seeking appeared to be substantially lower than expressed patient intent; although 78% of surveyed members of the German public59 and 79% of general hospital patients in Japan62 reported willingness to seek a second opinion for a cancer diagnosis, only 1.6% of >2.6 million Japanese cancer patients did so, possibly due to consultation fees and cultural deference.65 Low reported frequencies of second-opinion seeking may reflect limited patient awareness; indeed, in another German study, 94% of patient respondents expressed a desire for a second opinion but only 20% knew it was available.66 Barriers to second-opinion seeking among cancer patients include shock following diagnosis; time pressures; information overload; and fear of harming the patient–clinician relationship.67 Limited patient awareness66 and patient-related factors further contribute.1,6,9,12,68 These findings highlight the need for patient education on the availability, purpose and implications of second opinions, and how to interpret potentially conflicting information.
This review has several limitations. It was not systematic, lacked quantitative analysis, and drew on studies with substantial methodological heterogeneity, many of which relied on self-reported data with variable and inconsistent findings. As a result, evidence quality and comparability were limited, and few studies examined inequities in access to, or the cost-effectiveness of, second opinions. Despite these constraints, this review offers a broad overview of patient-initiated second opinions in oncology, outlining key trends, challenges, evidence gaps, and opportunities for advancement, including patient education.
Further research is needed to define the incidence and impact of second opinions in oncology. Key priorities include inequity analyses, cost-effectiveness evaluations, and clarification of the patient groups who derive the greatest benefit. Broader use of collaborative decision-making models (eg, tumor boards) and second-opinion programs could reduce unnecessary consultations and improve outcomes capture, equity access, and reporting consistency. Emerging artificial intelligence tools may also contribute. Together, these strategies could strengthen the evidence base and optimize the role of second opinions in oncology care.
Conclusions
Second opinions are sought by increasing numbers of oncology patients and, despite wide variation across populations and healthcare systems, consistently provide meaningful clinical and informational benefit. Use is patterned by demographic, socioeconomic and disease-related factors, with persistent inequities linked to ethnicity, language, education, income, insurance status and geography. Patients most often seek additional information, reassurance and expert confirmation. In turn, second opinions frequently improve guideline adherence and lead to clinically relevant changes in diagnosis, staging or treatment recommendations. Patient satisfaction is generally high, although influenced by care pathways and patient characteristics. Overall, these findings highlight the value of second opinions in enhancing care quality while underscoring the need to improve patient education and address other barriers to equitable access.
Supplementary Material
Acknowledgments
The author wishes to thank Caroline Patrick, medical writer, for her assistance with the research and development of this manuscript.
Author contributions
Mohammad Jahanzeb (Conceptualization, Formal analysis, Funding acquisition, Methodology, Resources, Supervision, Writing—review & editing)
Supplementary material
Supplementary material is available at The Oncologist online.
Funding
None declared.
Conflicts of interest
None declared.
Data availability
The data presented in this study are available on reasonable request from the author.
References
- 1. Tattersall MHN, Dear RF, Jansen J, et al. Second opinions in oncology: the experiences of patients attending the Sydney Cancer Centre. Med J Aust. 2009;191:209-212. [DOI] [PubMed] [Google Scholar]
- 2. Moumjid N, Gafni A, Bremond A, et al. Seeking a second opinion: do patients need a second opinion when practice guidelines exist? Health Policy. 2007;80:43-50. [DOI] [PubMed] [Google Scholar]
- 3. Ziebland S, Chapple A, Dumelow C, et al. How the internet affects patients’ experience of cancer: a qualitative study. BMJ. 2004;328:564. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 4. Beer M, Allison H, Fisher C, et al. Second opinions in breast cancer surgery: what have we learned? Cureus. 2022;14:e30180. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 5. Vashitz G, Pliskin JS, Parmet Y, et al. Do first opinions affect second opinions? J Gen Intern Med. 2012;27:1265-1271. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 6. Hillen MA, Medendorp NM, Daams JG, et al. Patient-driven second opinions in oncology: a systematic review. Oncologist. 2017;22:1197-1211. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 7. Maruzzo M, La Verde N, Russo A, et al. Second medical opinion in oncological setting. Crit Rev Oncol Hematol. 2021;160:103282. [DOI] [PubMed] [Google Scholar]
- 8. Greenfield G, Shmueli L, Harvey A, et al. Patient-initiated second medical consultations–patient characteristics and motivating factors, impact on care and satisfaction: a systematic review. BMJ Open. 2021;11:e044033. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 9. Payne VL, Singh H, Meyer AND, et al. Patient-initiated second opinions: systematic review of characteristics and impact on diagnosis, treatment, and satisfaction. Mayo Clin Proc. 2014;89:687-696. [DOI] [PubMed] [Google Scholar]
- 10. Ruetters D, Keinki C, Schroth S, et al. Is there evidence for a better health care for cancer patients after a second opinion? A systematic review. J Cancer Res Clin Oncol. 2016;142:1521-1528. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 11. Chang H-R, Yang M-C, Chung K-P. Can cancer patients seeking a second opinion get better care? Am J Manag Care. 2013;19:380-387. [PubMed] [Google Scholar]
- 12. Groß SE, Hillen MA, Pfaff H, et al. Second opinion in medical encounters – a study among breast cancer patients. Patient Educ Couns. 2017;100:1990-1995. [DOI] [PubMed] [Google Scholar]
- 13. Philip J, Gold M, Schwarz M, et al. Second medical opinions: the views of oncology patients and their physicians. Support Care Cancer. 2010;18:1199-1205. [DOI] [PubMed] [Google Scholar]
- 14. Schulmeyer CE, Beckmann MW, Fasching PA, et al. Improving the quality of care for cancer patients through oncological second opinions in a comprehensive cancer center: feasibility of patient-initiated second opinions through a health-insurance service point. Diagnostics. 2023;13:3300. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 15. Elmore JG, Tosteson ANA, Pepe MS, et al. Evaluation of 12 strategies for obtaining second opinions to improve interpretation of breast histopathology: simulation study. BMJ. 2016;353:i3069. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 16. Gagin R, HaGani N, Zigelboim E, et al. Patient-initiated second opinions during acute hospital care. Patient Exp J. 2019;6:66-73. [Google Scholar]
- 17. Lipitz-Snyderman A, Chimonas S, Mailankody S, et al. Clinical value of second opinions in oncology: a retrospective review of changes in diagnosis and treatment recommendations. Cancer Med. 2023;12:8063-8072. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 18. McCranie A, Lee AD, Leonard L, et al. Exploration of patient retention in seeking a second opinion: a retrospective cohort study. J Surg Res. 2025;306:588-603. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 19. Benbassat J. Obtaining a second opinion is a neglected source of health care inequalities. Isr J Health Policy Res. 2019;8:12. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 20. Garcia D, Spruill LS, Irshad A, et al. The value of a second opinion for breast cancer patients referred to a national cancer institute (NCI)-designated cancer center with a multidisciplinary breast tumor board. Ann Surg Oncol. 2018;25:2953-2957. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 21. Mellink WAM, Henzen-Logmans SC, Bongaerts AHH, et al. Discrepancy between second and first opinion in surgical oncological patients. Eur J Surg Oncol. 2006;32:108-112. [DOI] [PubMed] [Google Scholar]
- 22. Blazek A, O’Donoghue C, Terranella S, et al. Impact of inequities on delay in breast cancer management in women undergoing second opinions. J Surg Res. 2021;268:445-451. [DOI] [PubMed] [Google Scholar]
- 23. Lehmann V, Smets EMA, de Jong M, et al. Patient–provider communication during second opinion consultations in oncology. Patient Educ Couns. 2021;104:2490-2497. [DOI] [PubMed] [Google Scholar]
- 24. Greenfield G, Pliskin JS, Feder-Bubis P, et al. Patient–physician relationships in second opinion encounters – the physicians’ perspective. Soc Sci Med. 2012;75:1202-1212. [DOI] [PubMed] [Google Scholar]
- 25. Heeg E, Civil YA, Hillen MA, et al. Impact of second opinions in breast cancer diagnostics and treatment: a retrospective analysis. Ann Surg Oncol. 2019;26:4355-4363. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 26. De Heus E, Engelen V, Dingemans I, et al. Differences in health care experiences between rare cancer and common cancer patients: results from a national cross‑sectional survey. Orphanet J Rare Dis. 2021;16:249. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 27. Goldman RE, Sullivan A, Back AL, et al. Reflections on communication in the second-opinion hematology–oncology consultation. Pat Educ Couns. 2009;76:44-50. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 28. Golorsky D, Greenstein SH. Retrospective analysis of patients self-referred to comprehensive ophthalmology seeking second opinions. Clin Ophthalmol. 2013;7:1099-1102. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 29. Hillen MA, Smets EMA, Stouthard JM, et al. Cancer patients’ trust as a motivator to seek a second opinion and its effects on trust. Psychol Health. 2023;38:1109-1127. [DOI] [PubMed] [Google Scholar]
- 30. Fuchs T, Hanaya H, Seilacher E, et al. Is there evidence for a better health care for cancer patients after a second opinion? A systematic review. Cancer Invest. 2017;1:62-69. [DOI] [PubMed] [Google Scholar]
- 31. Olver I, Carey M, Bryant J, et al. Second opinions in medical oncology. BMC Palliative Care. 2020;19:112. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 32. Radhakrishnan A, Grande D, Mitra N, et al. Second opinions from urologists for prostate cancer: who gets them, why, and their link to treatment. Cancer. 2017;123:1027-1034. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 33. Tam KF, Cheng DKL, Ng TY, et al. The behaviors of seeking a second opinion from other health-care professionals and the utilization of complementary and alternative medicine in gynecologic cancer patients. Support Care Cancer. 2005;13:679-684. [DOI] [PubMed] [Google Scholar]
- 34. De Roo AC, Morris AM, Vu JV, et al. Characteristics of patients seeking second opinions at a multidisciplinary colorectal cancer clinic. Dis Colon Rectum. 2020;63:788-795. [DOI] [PubMed] [Google Scholar]
- 35. Goud RS, Jotwani AK, Poovaiah T, et al. Attributes and disease characteristics of patients seeking online second opinion for cancer. JCO. 2021;39:e13620. [Google Scholar]
- 36. Nagler RH, Gray SW, Romantan A, et al. Differences in information seeking among breast, prostate, and colorectal cancer patients: results from a population-based survey. Patient Educ Couns. 2010;81:S54-S62. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 37. Lund M, Bramley AM, Iyengar RG, et al. Factors that influence seeking second opinions, patient satisfaction, and education in breast cancer care: an internet-based study. Cancer Res. 2009;69:3107. [Google Scholar]
- 38. Pollack CE, Rastegar A, Keating NL, et al. Is self-referral associated with higher quality care? Health Serv Res. 2015;50:1472-1490. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 39. Minamitani M, Mukai T, Ogita M, et al. Relationship between consulting for second medical opinions, radiotherapy, and satisfaction with therapy, analyzed by structural equation modeling: a web-based survey. Asian Pac J Cancer Prev. 2021;22:2889-2896. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 40. Mordechai O, Tamir S, Weyl-Ben-Arush M. Seeking a second opinion in pediatric oncology. Pediatr Hematol Oncol. 2015;32:284-289. [DOI] [PubMed] [Google Scholar]
- 41. Xu J, Dailey RK, Eggly S, et al. Men’s perspectives on selecting their prostate cancer treatment. J Natl Med Assoc. 2011;103:468-478. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 42. Parikh AR, Kaplan CP, Burke NJ, et al. Ductal carcinoma in situ: knowledge of associated risks and prognosis among latina and non-Latina white women. Breast Cancer Res Treat. 2013;141:261-268. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 43. Kurian AW, Friese CR, Bondarenko I, et al. Second opinions from medical oncologists for early-stage breast cancer: prevalence, correlates and consequences. JAMA Oncol. 2017;3:391-397. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 44. Sanchez S, Adamowicz I, Chrusciel J, et al. Predictive factors of diagnostic and therapeutic divergence in a nationwide cohort of patients seeking second medical opinion. BMC Health Serv Res. 2021;21:902. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 45. Al Achkar M, Basu Roy U, Manley E Jr, et al. A qualitative study of interactions with oncologists among patients with advanced lung cancer. Support Care Cancer. 2022;30:9049-9055. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 46. Loehberg CR, Meyer J, Häberle L, et al. Analysis of motives and patient satisfaction in oncological second opinions provided by a certified university breast and gynecological cancer center. Arch Gynecol Obstet. 2020;301:1299-1306. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 47. Hillen MA, Gutheil CM, Smets EMA, et al. The evolution of uncertainty in second opinions about prostate cancer treatment. Health Expect. 2017;20:1264-1274. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 48. Denberg TD, Melhado TV, Steiner JF. Patient treatment preferences in localized prostate carcinoma: the influence of emotion, misconception, and anecdote. Cancer. 2006;107:620-630. [DOI] [PubMed] [Google Scholar]
- 49. Rajan R, Jotwani AK, Poovaiah T, et al. An analysis of the reasons and motives of patients seeking telehealth-based second opinion for cancer. J Clin Oncol. 2021;39:e13621. [Google Scholar]
- 50. Philip J, Gold M, Schwarz M, et al. An exploration of the dynamics and influences upon second medical opinion consultations in cancer care. Asia Pac J Clin Oncol. 2011;7:41-46. [DOI] [PubMed] [Google Scholar]
- 51. Lehmann V, Smets EMA, de Jong M, et al. Reducing uncertainty: motivations and consequences of seeking a second opinion in oncology. Acta Oncol. 2020;59:1512-1519. [DOI] [PubMed] [Google Scholar]
- 52. Hillen MA, Woei-A-Jin FJSH, Smets EMA, et al. Assessment of challenges encountered by Dutch oncologists when patients ask for second opinions. JAMA Oncol. 2018;4:1425-1426. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 53. Coffey K, Mango V, Keating DM, et al. The impact of patient-initiated subspecialty review on patient care. J Am Coll Radiol. 2018;15:1109-1115. [DOI] [PubMed] [Google Scholar]
- 54. Ramsey SD, Zeliadt SB, Fedorenko CR, et al. Patient preferences and urologist recommendations among local-stage prostate cancer patients who present for initial consultation and second opinions. World J Urol. 2011;29:3-9. [DOI] [PubMed] [Google Scholar]
- 55. Meyer AND, Singh H, Graber ML. Evaluation of outcomes from a national patient-initiated second-opinion program. Am J Med. 2015;128:1138.e25-1138.e33. [DOI] [PubMed] [Google Scholar]
- 56. Khazai L, Middleton LP, Goktepe N, et al. Breast pathology second review identifies clinically significant discrepancies in over 10% of patients. J Surg Oncol. 2015;111:192-197. [DOI] [PubMed] [Google Scholar]
- 57. Schook RM, ter Avest MJ, van Setten CH, et al. Lung cancer patients benefit from second opinions by improvement of diagnosis and therapy. Cancer Clin Oncol. 2014;3:43-57. [Google Scholar]
- 58. Lux MP, Wasner S, Meyer J, et al. Analysis of oncological second opinions in a certified university breast and gynecological cancer center regarding consensus between the first and second opinion and conformity with the guidelines. Breast Care. 2021;16:291-298. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 59. Könsgen N, Prediger B, Schlimbach A, et al. Attitude toward second opinions in Germany–a survey of the general population. BMC Health Serv Res. 2022;22:76. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 60. Van der Velden NCA, van der Kleij MBA, Lehmann V, et al. Communication about prognosis during patient-initiated second opinion consultations in advanced cancer care: an observational qualitative analysis. Int J Environ Res Public Health. 2021;18:5694. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 61. Palmieri B, Laurino C, Vadalà M. The “second opinion medical network”. Int J Pathol Clin Res. 2017;3:056. [Google Scholar]
- 62. Okamoto S, Kawahara K, Okawa A, et al. An exploration of the dynamics and influences upon second medical opinion consultations in cancer care. Health Expect. 2015;18:826-838.23409806 [Google Scholar]
- 63. Fry A, White B, Nagarwalla D, et al. Relationship between ethnicity and stage at diagnosis in England: a national analysis of six cancer sites. BMJ Open. 2023;13:e062079. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 64. Hirko KA, Rocque G, Reasor E, et al. The impact of race and ethnicity in breast cancer—disparities and implications for precision oncology. BMC Med. 2022;20:72. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 65. Takasawa M, Teramoto N, Yamashita N, et al. Second opinion referrals of cancer patients in Japan—a nationwide study. Cancer Sci. 2025;116:1417-1423. [DOI] [PMC free article] [PubMed] [Google Scholar]
- 66. Oskay-Özcelik G, Lehmacher W, Könsgen D, et al. Breast cancer patients’ expectations in respect of the physician–patient relationship and treatment management results of a survey of 617 patients. Ann Oncol. 2007;18:479-484. [DOI] [PubMed] [Google Scholar]
- 67. Peier-Ruser KS, von Greyerz S. Why do cancer patients have difficulties evaluating the need for a second opinion and what is needed to lower the barrier? A qualitative study. Oncol Res Treat. 2018;41:769-773. [DOI] [PubMed] [Google Scholar]
- 68. Cecon N, Hillen MA, Pfaff H, et al. Why do newly diagnosed breast cancer patients seek a second opinion? Second opinion seeking and its association with the physician-patient relationship. Patient Educ Couns. 2019;102:998-1004. [DOI] [PubMed] [Google Scholar]
- 69. Chan TY, Epstein JI. Patient and urologist driven second opinion of prostate needle biopsies. J Urol. 2005;174:1390-1394. [DOI] [PubMed] [Google Scholar]
Associated Data
This section collects any data citations, data availability statements, or supplementary materials included in this article.
Supplementary Materials
Data Availability Statement
The data presented in this study are available on reasonable request from the author.
